Kohortenstudie
Malignancy Risk in Autoimmune Blistering Disorders: A Retrospective Cohort Study
Journal of Drugs in Dermatology · 01.05.2026 · 25 (5) · e47-e48
DOI: 10.36849/jdd.9893 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.04.2026. Verfasst von Robert Adler und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Adler, R., Martins, K., Tsang, L., Kozlov, M., Mehta, M. D., Cowen, E., Svigos, K., Marson, J., & Feig, J. L. (2026). Malignancy Risk in Autoimmune Blistering Disorders: A Retrospective Cohort Study. Journal of Drugs in Dermatology, 25(5), e47-e48. https://doi.org/10.36849/jdd.9893
Vancouver
Adler R, Martins K, Tsang L, Kozlov M, Mehta MD, Cowen E, et al. Malignancy Risk in Autoimmune Blistering Disorders: A Retrospective Cohort Study. Journal of Drugs in Dermatology. 2026;25(5):e47-e48. doi:10.36849/jdd.9893
BibTeX
@article{Adler2026,
author = {Adler, Robert and Martins, Kaitlin and Tsang, Lori and Kozlov, Michael and Mehta, Manan D and Cowen, Emily and Svigos, Katerina and Marson, Justin and Feig, Jessica Lori},
title = {Malignancy Risk in Autoimmune Blistering Disorders: A Retrospective Cohort Study},
journal = {Journal of Drugs in Dermatology},
year = {2026},
volume = {25},
number = {5},
pages = {e47--e48},
doi = {10.36849/jdd.9893}
}
EUVIMED